Whalesbook
Pharma Sector Dominates Investment
Indian pharmaceutical giants are leading this record U.S. investment, committing over $19.1 billion. Sun Pharmaceutical Industries Ltd. is at the forefront with its planned $11.75 billion acquisition of Organon & Co., signaling market consolidation and expansion. Other leading Indian drugmakers, including Aurobindo Pharma Ltd., Biocon Group, Cipla Limited, Dr. Reddy's Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Granules India Ltd, Lupin Limited, Piramal Pharma Ltd., and Zydus Lifesciences Limited, are also committing substantial funds. Their focus includes enhancing manufacturing, supporting research and development initiatives, and establishing new facilities to address drug shortages and strengthen the U.S. healthcare supply chain.
Industrial Growth and Manufacturing
Beyond healthcare, industrial conglomerates are expanding their U.S. footprint. JSW Steel plans $255 million in modernization projects across its Ohio and Texas facilities. Meanwhile, 12 Indian companies announced new projects and expansions worth over $1.1 billion. Notably, the Ahmedabad-based Abhyuday Group committed over $900 million across five U.S. sites, creating 1,500 American jobs. Jindal Pipe and Jindal Tubular USA are investing $87 million in Texas and Mississippi, while Jivo Wellness is investing $15 million in its U.S. operations. Polyhose Inc. is investing $2 million in Los Angeles to support the U.S. shipbuilding industry.
Tech and Energy Investments
The technology and digital infrastructure sector is also a key recipient of Indian capital. Sterlite Technologies Ltd., based in Mumbai, is investing $100 million to strengthen AI and telecom infrastructure, expected to generate 500 jobs. Techdome Solutions, RoshAi, Atri AI, Kissflow, and SatoriXR are making smaller but significant investments, ranging from $1.5 million to $7.5 million across various states, collectively creating nearly 150 jobs. In energy, MagnoInnovation Lab will invest $2 million to launch U.S. field operations.
Boosting U.S.-India Trade
These investments are projected to create thousands of U.S. jobs, strengthen supply chains, and expand production capacity. U.S. Ambassador to India Sergio Gor called these commitments evidence of the U.S. market's attractiveness to foreign investors. He reiterated the goal to double U.S.-India bilateral trade to $500 billion by 2030, aiming for fair, balanced, and mutually beneficial trade.